Subscribe now
Keven Esvelt

Pandemic terrorism risk is being overlooked, warns leading geneticist

14 November 2022

Kevin Esvelt, who created the first artificial gene drive capable of wiping out an entire species, says the threat of a deliberately released virus causing a pandemic is being overlooked


A Moderna covid-19 vaccine is prepared

Covid-19 news: Moderna’s omicron booster has promising immune response

9 June 2022

A regular round-up of the latest coronavirus news, plus insight, features and interviews from New Scientist about the covid-19 pandemic


A person walks past a mural of medical workers in Mérida, Mexico, in February

Should I worry about 'deltacron' and other covid-19 recombinants?

31 March 2022

Recombination, essentially the viral version of sex, occurs when a single cell is simultaneously infected with two related viruses, whose genetic material could mix as they replicate


coronavirus

Beta covid-19 variant (B.1.351)

16 February 2021

The beta coronavirus variant or B1.351, which was first identified in South Africa


2021 preview: How soon will a covid-19 vaccine return life to normal?

2021 preview: How soon will a covid-19 vaccine return life to normal?

24 December 2020

We have a coronavirus vaccine, but normal life is still some way off. In the meantime, here are the big issues facing us in the months ahead


What are mRNA vaccines and how useful will they be?

What are mRNA vaccines and how useful will they be?

18 November 2020

Coronavirus vaccines being developed by Pfizer and Moderna could be the first mRNA vaccines to get approval. Here's how these vaccines work and how might they change the world


When did the coronavirus really reach the US and Europe?

When did the coronavirus really reach the US and Europe?

23 September 2020

While there may have been a few cases outside Wuhan as early as December, it appears the virus did not become widespread until months later


Is the rush to roll out a coronavirus vaccine undermining safety?

Is the rush to roll out a coronavirus vaccine undermining safety?

26 August 2020

Some shortcuts are being taken in the race to get a coronavirus vaccine approved, but there are also more resources, openness and scrutiny than ever before


Remdesivir

Remdesivir

29 May 2020

Remdesivir is an antiviral drug that has provisional approval in several countries for treating people with severe coronavirus infections. It has been shown to shorten recovery time in people with covid-19 but not to reduce mortality.


Sign up to our weekly newsletter

Receive a weekly dose of discovery in your inbox. We'll also keep you up to date with New Scientist events and special offers.

Sign up
Piano Exit Overlay Banner Mobile Piano Exit Overlay Banner Desktop